SHL Stock Overview
Offers medical diagnostic and administrative services to medical practitioners, hospitals, community health services, and patients in Australia, the United States, Germany, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Sonic Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$27.50 |
| 52 Week High | AU$32.57 |
| 52 Week Low | AU$23.58 |
| Beta | 0.51 |
| 1 Month Change | -1.75% |
| 3 Month Change | 4.60% |
| 1 Year Change | -13.22% |
| 3 Year Change | -40.36% |
| 5 Year Change | -6.68% |
| Change since IPO | 27,400.00% |
Recent News & Updates
Recent updates
Sonic Healthcare Limited's (ASX:SHL) Popularity With Investors Is Under Threat From Overpricing
Nov 28
Sonic Healthcare Limited's (ASX:SHL) Intrinsic Value Is Potentially 93% Above Its Share Price
Jul 27These 4 Measures Indicate That Sonic Healthcare (ASX:SHL) Is Using Debt Reasonably Well
Jun 24Sonic Healthcare Limited (ASX:SHL) Investors Are Less Pessimistic Than Expected
May 08Sonic Healthcare's (ASX:SHL) Returns On Capital Not Reflecting Well On The Business
Apr 24Sonic Healthcare Limited's (ASX:SHL) Intrinsic Value Is Potentially 90% Above Its Share Price
Mar 07Returns On Capital At Sonic Healthcare (ASX:SHL) Have Hit The Brakes
Dec 26Shareholder Returns
| SHL | AU Healthcare | AU Market | |
|---|---|---|---|
| 7D | -2.1% | -2.7% | -0.6% |
| 1Y | -13.2% | -4.2% | 9.1% |
Return vs Industry: SHL underperformed the Australian Healthcare industry which returned -4.2% over the past year.
Return vs Market: SHL underperformed the Australian Market which returned 9.1% over the past year.
Price Volatility
| SHL volatility | |
|---|---|
| SHL Average Weekly Movement | 3.0% |
| Healthcare Industry Average Movement | 5.6% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in AU Market | 16.7% |
| 10% least volatile stocks in AU Market | 3.1% |
Stable Share Price: SHL has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: SHL's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1934 | 42,000 | Colin Goldschmidt | www.sonichealthcare.com |
Sonic Healthcare Limited offers medical diagnostic and administrative services to medical practitioners, hospitals, community health services, and patients in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, general practice IT solutions, and community-based healthcare services.
Sonic Healthcare Limited Fundamentals Summary
| SHL fundamental statistics | |
|---|---|
| Market cap | AU$13.41b |
| Earnings (TTM) | AU$511.09m |
| Revenue (TTM) | AU$8.97b |
25.8x
P/E Ratio1.5x
P/S RatioIs SHL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SHL income statement (TTM) | |
|---|---|
| Revenue | AU$8.97b |
| Cost of Revenue | AU$6.02b |
| Gross Profit | AU$2.94b |
| Other Expenses | AU$2.43b |
| Earnings | AU$511.09m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.06 |
| Gross Margin | 32.84% |
| Net Profit Margin | 5.70% |
| Debt/Equity Ratio | 37.0% |
How did SHL perform over the long term?
See historical performance and comparisonDividends
3.9%
Current Dividend Yield99%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 07:53 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sonic Healthcare Limited is covered by 32 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Dennis Hulme | APP Securities Pty Ltd. |
| Russell Wright | Barclay Pearce Capital Pty Limited |
| Benjamin Brayshaw | Barrenjoey Markets Pty Limited |